Table of Contents Author Guidelines Submit a Manuscript
Journal of Nanomaterials
Volume 2018 (2018), Article ID 2603712, 6 pages
https://doi.org/10.1155/2018/2603712
Research Article

Doxorubicin-Loaded Melanin Particles for Enhanced Chemotherapy in Drug-Resistant Anaplastic Thyroid Cancer Cells

1Department of Endocrinology, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing 211100, China
2Department of Medical Imaging, Jinling Hospital, School of Medicine, Nanjing University, Nanjing 210000, China
3Department of Oncology, The Affiliated Bayi Hospital of Nanjing University of Chinese Medicine, Nanjing 210002, China

Correspondence should be addressed to Kun Wang

Received 19 October 2017; Revised 10 January 2018; Accepted 17 January 2018; Published 11 February 2018

Academic Editor: Ester Vazquez

Copyright © 2018 Kun Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Davies and H. G. Welch, “Increasing incidence of thyroid cancer in the United States, 1973–2002,” Journal of the American Medical Association, vol. 295, no. 18, pp. 2164–2167, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. R.-Y. Lin, “Thyroid cancer stem cells,” Nature Reviews Endocrinology, vol. 7, no. 10, pp. 609–616, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Molinaro, C. Romei, A. Biagini et al., “Anaplastic thyroid carcinoma: From clinicopathology to genetics and advanced therapies,” Nature Reviews Endocrinology, vol. 13, no. 11, pp. 644–660, 2017. View at Publisher · View at Google Scholar · View at Scopus
  4. P. J. Davis, S. Incerpi, H.-Y. Lin, H.-Y. Tang, T. Sudha, and S. A. Mousa, “Thyroid hormone and P-glycoprotein in tumor cells,” BioMed Research International, vol. 2015, Article ID 168427, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. X. Zheng, D. Cui, S. Xu, G. Brabant, and M. Derwahl, “Doxorubicin fails to eradicate cancer stem cells derived from anaplastic thyroid carcinoma cells: Characterization of resistant cells,” International Journal of Oncology, vol. 37, no. 2, pp. 307–315, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Massart, C. Poirier, P. Fergelot, O. Fardel, and J. Gibassier, “Effect of sodium butyrate on doxorubicin resistance and expression of multidrug resistance genes in thyroid carcinoma cells,” Anti-Cancer Drugs, vol. 16, no. 3, pp. 255–261, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Chen, S. Xu, K. Renko, and M. Derwahl, “Metformin inhibits growth of thyroid carcinoma cells, suppresses self-renewal of derived cancer stem cells, and potentiates the effect of chemotherapeutic agents,” The Journal of Clinical Endocrinology & Metabolism, vol. 97, no. 4, pp. E510–E520, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Zeng, Y. Pan, Y. Tian et al., “Doxorubicin-Loaded NaYF4:Yb/Tm–TiO2 Inorganic Photosensitizers for NIR-Triggered Photodynamic Therapy and Enhanced Chemotherapy in Drug-Resistant Breast Cancerscancers,” Biomaterials, vol. 57, pp. 93–106, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. X. Wang, Y. Liu, S. Wang et al., “CD44-engineered mesoporous silica nanoparticles for overcoming multidrug resistance in breast cancer,” Applied Surface Science, vol. 332, pp. 308–317, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. M. C. Cristiano, D. Cosco, C. Celia et al., “Anticancer activity of all-trans retinoic acid-loaded liposomes on human thyroid carcinoma cells,” Colloids and Surfaces B: Biointerfaces, vol. 150, pp. 408–416, 2017. View at Publisher · View at Google Scholar · View at Scopus
  11. C. L. Gigliotti, B. Ferrara, S. Occhipinti et al., “Enhanced cytotoxic effect of camptothecin nanosponges in anaplastic thyroid cancer cells in vitro and in vivo on orthotopic xenograft tumors,” Drug Delivery, vol. 24, no. 1, pp. 670–680, 2017. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Liu, K. Ai, J. Liu, M. Deng, Y. He, and L. Lu, “Dopamine-melanin colloidal nanospheres: An efficient near-infrared photothermal therapeutic agent for in vivo cancer therapy,” Advanced Materials, vol. 25, no. 9, pp. 1353–1359, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. X. Wang, J. Zhang, Y. Wang et al., “Multi-responsive photothermal-chemotherapy with drug-loaded melanin-like nanoparticles for synergetic tumor ablation,” Biomaterials, vol. 81, pp. 114–124, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. Q. Fan, K. Cheng, X. Hu et al., “Transferring biomarker into molecular probe: Melanin nanoparticle as a naturally active platform for multimodality imaging,” Journal of the American Chemical Society, vol. 136, no. 43, pp. 15185–15194, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Liopo, R. Su, and A. A. Oraevsky, “Melanin nanoparticles as a novel contrast agent for optoacoustic tomography,” Photoacoustics, vol. 3, no. 1, pp. 35–43, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. W.-Q. Li, Z. Wang, S. Hao et al., “Mitochondria-Targeting Polydopamine Nanoparticles to Deliver Doxorubicin for Overcoming Drug Resistance,” ACS Applied Materials & Interfaces, vol. 9, no. 20, pp. 16793–16802, 2017. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Wang, Y. Tian, W. Tian et al., “Selectively Sensitizing Malignant Cells to Photothermal Therapy Using a CD44-Targeting Heat Shock Protein 72 Depletion Nanosystem,” ACS Nano, vol. 10, no. 9, pp. 8578–8590, 2016. View at Publisher · View at Google Scholar · View at Scopus